We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-0.76%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$282M
Cap. Flow
+$504M
Cap. Flow %
4.41%
Top 10 Hldgs %
13.8%
Holding
2,664
New
339
Increased
765
Reduced
639
Closed
146

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 13.66%
3 Industrials 12.88%
4 Financials 10.57%
5 Energy 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTA
2301
DELISTED
Universal Travel Group New Common Stock
UTA
$0 ﹤0.01%
+2,500
New
GCVRZ
2302
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
+294
New +$143
AAN.A
2303
DELISTED
The Aaron's Company Inc Class A
AAN.A
$0 ﹤0.01%
19
-1,246
-98%

Similar funds

Glenmede Trust's Q3 2014 Portfolio in Review

As of Q3 2014, Glenmede Trust held 2,664 positions worth $11.4B, up 2.5% from $11.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $504M of net new capital in Q3 2014, opening 339 new positions and adding to 765 existing holdings. Its largest new stake was Acadia Healthcare: 426,301 shares worth $20.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Spirit Airlines, Inc., an estimated $22.2M trimmed.

  • Glenmede Trust's largest Q3 2014 buy was Acadia Healthcare: 426,301 shares worth $20.7M.
  • Glenmede Trust added most to Brunswick in Q3 2014, an estimated $24.1M increase.
  • Glenmede Trust's biggest Q3 2014 reduction was Spirit Airlines, Inc., cutting an estimated $22.2M.
  • Glenmede Trust fully exited Unisys in Q3 2014, selling an estimated $13.5M.
  • Glenmede Trust's ten largest holdings make up 14% of its $11.4B portfolio in Q3 2014.
  • Glenmede Trust opened 339 new positions and closed 146 in Q3 2014.
  • Glenmede Trust's portfolio value rose 2.5% quarter-over-quarter to $11.4B.

Based on Glenmede Trust's 13F filing for Q3 2014, filed 14 Nov 2014.